Business Description
Kaken Pharmaceutical Co Ltd
NAICS : 325411
SIC : 2833
ISIN : JP3207000005
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 21.82 | |||||
Equity-to-Asset | 0.83 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | 0.16 | |||||
Interest Coverage | 1123.05 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 5.52 | |||||
Beneish M-Score | -1.98 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -0.6 | |||||
3-Year EBITDA Growth Rate | -15.1 | |||||
3-Year EPS without NRI Growth Rate | -13.9 | |||||
3-Year FCF Growth Rate | -67.4 | |||||
3-Year Book Growth Rate | 2.2 | |||||
Future 3-5Y EPS without NRI Growth Rate | -37.14 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 33.75 | |||||
9-Day RSI | 39.65 | |||||
14-Day RSI | 45.48 | |||||
6-1 Month Momentum % | 17.67 | |||||
12-1 Month Momentum % | 36.92 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.18 | |||||
Quick Ratio | 4.47 | |||||
Cash Ratio | 3.55 | |||||
Days Inventory | 188.12 | |||||
Days Sales Outstanding | 97.6 | |||||
Days Payable | 77.58 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 3.52 | |||||
Dividend Payout Ratio | 0.3 | |||||
Forward Dividend Yield % | 3.52 | |||||
5-Year Yield-on-Cost % | 3.57 | |||||
3-Year Average Share Buyback Ratio | 0.4 | |||||
Shareholder Yield % | 3.52 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 60.66 | |||||
Operating Margin % | 27.03 | |||||
Net Margin % | 20.91 | |||||
FCF Margin % | 0.47 | |||||
ROE % | 12.6 | |||||
ROA % | 10.44 | |||||
ROIC % | 19.81 | |||||
ROC (Joel Greenblatt) % | 46.88 | |||||
ROCE % | 15.23 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 8.77 | |||||
Forward PE Ratio | 53.1 | |||||
PE Ratio without NRI | 8.52 | |||||
Shiller PE Ratio | 9.96 | |||||
PS Ratio | 1.83 | |||||
PB Ratio | 1.03 | |||||
Price-to-Tangible-Book | 1.09 | |||||
Price-to-Free-Cash-Flow | 388.59 | |||||
Price-to-Operating-Cash-Flow | 61.83 | |||||
EV-to-EBIT | 3.41 | |||||
EV-to-EBITDA | 3.23 | |||||
EV-to-Revenue | 0.91 | |||||
EV-to-FCF | 197.79 | |||||
Price-to-Projected-FCF | 0.66 | |||||
Price-to-Median-PS-Value | 0.8 | |||||
Price-to-Graham-Number | 0.64 | |||||
Price-to-Net-Current-Asset-Value | 1.78 | |||||
Price-to-Net-Cash | 3.12 | |||||
Earnings Yield (Greenblatt) % | 29.3 | |||||
FCF Yield % | 0.25 | |||||
Forward Rate of Return (Yacktman) % | -10.79 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Kaken Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil 円) | 87,245 | ||
EPS (TTM) (円) | 481.641 | ||
Beta | 0.01 | ||
Volatility % | 14.67 | ||
14-Day RSI | 45.48 | ||
14-Day ATR (円) | 74.15262 | ||
20-Day SMA (円) | 4299.05 | ||
12-1 Month Momentum % | 36.92 | ||
52-Week Range (円) | 3252 - 4577 | ||
Shares Outstanding (Mil) | 37.87 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Kaken Pharmaceutical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Kaken Pharmaceutical Co Ltd Stock Events
Event | Date | Price(円) | ||
---|---|---|---|---|
No Event Data |
Kaken Pharmaceutical Co Ltd Frequently Asked Questions
What is Kaken Pharmaceutical Co Ltd(TSE:4521)'s stock price today?
When is next earnings date of Kaken Pharmaceutical Co Ltd(TSE:4521)?
Does Kaken Pharmaceutical Co Ltd(TSE:4521) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |